Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
Sunday, September 15, 2024 9:37 PM EDT Some Background Shares of clinical-stage companies developing treatments based on psychedelic compound-based drugs moved lower in early August after the U.S. Food and Drug Administration (FDA) rejected the use of MDMA …